Frutarom targets bladder health with Go-Less
formulation to targets both the symptoms and causes of incontinence
and an overactive bladder.
Proprietary Go-Less is being unveiled at Supply Side East in New Jersey, and is geared towards supporting bladder health in aging men and women. The manufacturer has combined its pumpkin seed extract, EFLA 940, with its SoyLife soy germ isoflavone extract. SoyLife helps prevent the causes of incontinence - Laurent Leduc, vice president marketing & business development Frutarom USA, told NutraIngredients-USA - while the proprietary pumpkin extract targets the symptoms. EFLA 940 is water-soluble extract that has been purified to remove the fat-soluble components that can cause rancidity, while SoyLife is a patented soy germ isoflavone that has been shown in clinical studies to regulate hormone levels. "Several human studies in both men and women have shown the ingredients in Go-Less to be effective at supporting bladder health. The blend was also well-tolerated, as the studies found no serious side effects," said Frutarom's technical specialist Jocelyn Mathern. According to the company, studies include a six-week long one involving 39 women between 52 and 86 years of age. When they were given a supplement with Frutarom's Go-Less ingredients, the subjects were reported to have a decrease in urination and a subsequent improvement in sleeping patterns. Another six-week study - with two groups of men over the age of 65 - looked at a condition called pollakuria that disturbs sleep because of the strong desire to urinate. Frutarom claims that among those participants who were given the company's blend over 86 percent reported a significant decrease in symptoms. Frutarom acquired Acatris Health in late 2006 and, according to Leduc, Go-Less is the brainchild of this union. "This is first success story after the aquisition," said Leduc. "Two companies combining ingredients and the science and marketing to support them." SoyLife was developed by Acatris, while Frutarom owned EFLA 940. Frutarom recommends a daily dosage of 600mg of Go-Less for use in applications ranging from capsules, tablets and softgels to beverages and bars. The Cystitis and Overactive Bladder Foundation suggests various factors for alleviating the symptoms of overactive bladder conditions: lifestyle changes, pelvic floor exercises, use of a pocket-sized urinal device, or medication.
